Contact About


List of participants:

1. ABNOBA GMBH, Pforzheim, Germany (Coordinator) 
    Department: Pharmaceutical Technologies

    Scientist-in-Charge: Dr. Gero Leneweit

2. Universiteit Utrecht, Utrecht, Netherlands
    Department: Pharmaceutics
Scientist-in-Charge: Prof. Dr. Robbert Jan Kok

3. Uppsala Universitet, Uppsala, Sweden
    Department: Immunology, Genetics & Pathology
Scientist-in-Charge: Prof. Dr. Bo Nilsson, MD

4. Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany
    Department: Mechanical Process Engineering
Scientist-in-Charge: Prof. Dr.-Ing. Hermann Nirschl








The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European
Union’s Seventh Framework Programme FP7 (2007–2013) under REA grant agreement no. 324275 (project acronym Decent AID)